Insider Trading activities of Vistagen Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vistagen Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vistagen Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Vistagen Therapeutics, Inc. since 2005. The reporting company's ticker symbol is VTGN. The reporting company's CIK number is 1411685.
The total value of stock buying since 2005 is $25,286.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $182,273.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Vistagen Therapeutics, Inc. (VTGN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-03 20,000 $25,286 0 $0 2,500 $3,750
2019-01 0 $0 0 $0 26,750 $40,124
2017-05 100,000 $0 0 $0 0 $0
2013-10 0 $0 0 $0 10,000 $6,400
2013-06 0 $0 0 $0 50,000 $32,000
2011-12 0 $0 0 $0 113,636 $99,999
2011-05 0 $0 4,982,103 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Vistagen Therapeutics, Inc. insiders (VTGN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-03-14 Saxe Jon S Buy 7,920 1.27 10,090
2019-03-13 Snodgrass H. Ralph (PRES./CHIEF SCIENTIFIC OFFICER) Option Ex 2,500 1.50 3,750
2019-03-13 Saxe Jon S Buy 12,080 1.26 15,196
2019-01-29 Saxe Jon S Option Ex 1,375 1.50 2,062
2019-01-14 Singh Shawn (CHIEF EXECUTIVE OFFICER) Option Ex 25,375 1.50 38,062
2017-05-31 Gin Jerry B Buy 100,000 .00 0
2013-10-15 Singh Shawn (CHIEF EXECUTIVE OFFICER) Option Ex 10,000 .64 6,400
2013-06-27 Singh Shawn (CHIEF EXECUTIVE OFFICER) Option Ex 50,000 .64 32,000
2011-12-20 Snodgrass H. Ralph (PRES./CHIEF SCIENTIFIC OFFICER) Option Ex 113,636 .88 99,999
2011-05-09 Jones Stephanie (PRESIDENT) Sale 4,982,103 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of VTGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vistagen Therapeutics, Inc. (symbol VTGN, CIK number 1411685) see the Securities and Exchange Commission (SEC) website.